: Overexpression of miRNAs reduces proliferation. Neuroblastoma cell lines were transfected with the indicated pre-miRs, and their growth was assessed using the xCELLigence system. Transfection time point is used for normalization (dotted line). IMR-32(A), NGP (B), N206 (C), SKNAS (D), SKNBE(2c) (E). Figure S2 : Survival and expression analysis of miR-432-5p. Kaplan-Meier progression-free survival curve for neuroblastoma patients (n=100) stratified according to miR-432-5p expression levels (quartiles) (log-rank test p-value) (A).
Comparison of miR-432-5p expression between neuroblasts and primary neuroblastoma tumors stratified according to MYCN status, data compared using rank product analysis. MNN (MYCN non-amplified neuroblastoma), MNA (MYCN amplified neuroblastoma) (B).
miR-432-5p expression is associated with progression free survival of neuroblastoma patients and is expressed higher in normal fetal neuroblasts
We analyzed the expression patterns of the aforementioned miRNAs in a cohort of 100 primary neuroblastoma tumors and human fetal adrenal neuroblasts (details in materials and methods), the latter being the cell of origin for neuroblastoma [7, 12] .
While the miRNAs were not significantly associated to overall survival, low expression of miR-432-5p was significantly associated with poor progression-free survival and shows lower expression in the MYCN-amplified neuroblastoma tumors as compared to the tumors without MYCN amplification. When comparing the expression of the 4 miRNAs between the neuroblastoma tumors and the neuroblasts, miR-432-5p and miR-203a show higher expression in the neuroblasts as compared to the neuroblastoma tumors (Figure 4 ).
